XML 54 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity (Tables)
6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Schedule of Stock by Class
Preferred stock authorized, issued and outstanding was as follows:
 
 
June 30, 2018
 
December 31, 2017
Series
 
Shares
Authorized
 
Shares
Issued
 
Shares
Outstanding
 
Shares
Authorized
 
Shares
Issued
 
Shares
Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A
 
27,600,000

 
24,000,000

 
24,000,000

 
27,600,000

 
24,000,000

 
24,000,000

5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C
 
1,500,000

 
1,500,000

 
1,500,000

 
1,500,000

 
1,500,000

 
1,500,000

5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D
 
500,000

 
500,000

 
500,000

 

 

 

5.625% Non-Cumulative Preferred Stock, Series E

 
32,200

 
32,200

 
32,200

 

 

 

Series A Junior Participating Preferred Stock
 
10,000,000

 

 

 
10,000,000

 

 

Not designated
 
160,367,800

 

 

 
160,900,000

 

 

Total
 
200,000,000

 
26,032,200

 
26,032,200

 
200,000,000

 
25,500,000

 
25,500,000

Dividend Payment Restrictions
The table below sets forth the dividends permitted to be paid in 2018 by MetLife, Inc.’s primary insurance subsidiaries without insurance regulatory approval and the respective dividends paid during the six months ended June 30, 2018:
Company
 
Paid (1)
 
Permitted Without
Approval (2)
 
 
(In millions)
Metropolitan Life Insurance Company
 
$
1,705

(3
)
 
$
3,075

American Life Insurance Company
 
$
1,500

(4
)
 
$

Metropolitan Property and Casualty Insurance Company
 
$



 
$
125

Metropolitan Tower Life Insurance Company (5)
 
$



 
$
73

General American Life Insurance Company (5)
 
$



 
N/A

__________________
(1)
Reflects all amounts paid, including those requiring regulatory approval.
(2)
Reflects dividend amounts that may be paid during 2018 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2018, some or all of such dividends may require regulatory approval.
(3)
Represents an ordinary dividend of $1.0 billion and an extraordinary dividend of $705 million that was paid with regulatory approval. The extraordinary dividend was paid in cash with proceeds from the sale to an affiliate of certain property, equipment, leasehold improvements and computer software that were non-admitted by Metropolitan Life Insurance Company for statutory accounting purposes. The affiliate received a capital contribution in cash from MetLife, Inc. to fund the purchase.
(4)
Represents an extraordinary dividend.
(5)
In April 2018, Metropolitan Tower Life Insurance Company (“MTL”) merged with General American Life Insurance Company (“GALIC”). The surviving entity of the merger was MTL, which re-domesticated from Delaware to Nebraska immediately prior to the merger. Effective as of the date of re-domestication, MTL is subject to the dividend restrictions under Nebraska law.
Components of Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., was as follows:
 
 
Three Months
Ended
June 30, 2018
 
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
 
(In millions)
Balance, beginning of period
 
$
10,864

 
$
683

 
$
(3,707
)
 
$
(2,206
)
 
$
5,634

OCI before reclassifications
 
(3,096
)
 
141

 
(969
)
 
3

 
(3,921
)
Deferred income tax benefit (expense)
 
706

 
41

 
6

 
(1
)
 
752

AOCI before reclassifications, net of income tax
 
8,474

 
865

 
(4,670
)
 
(2,204
)
 
2,465

Amounts reclassified from AOCI
 
83

 
470

 

 
31

 
584

Deferred income tax benefit (expense)
 
(19
)
 
(170
)
 

 
(6
)
 
(195
)
Amounts reclassified from AOCI, net of income tax
 
64

 
300

 

 
25

 
389

Balance, end of period
 
$
8,538

 
$
1,165

 
$
(4,670
)
 
$
(2,179
)
 
$
2,854

 
 
 
Three Months
Ended
June 30, 2017
 
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
 
(In millions)
Balance, beginning of period
 
$
11,336

 
$
1,853

 
$
(4,842
)
 
$
(1,951
)
 
$
6,396

OCI before reclassifications
 
3,290

 
(7
)
 
169

 
1

 
3,453

Deferred income tax benefit (expense)
 
(1,132
)
 
3

 
(6
)
 
3

 
(1,132
)
AOCI before reclassifications, net of income tax
 
13,494

 
1,849

 
(4,679
)
 
(1,947
)
 
8,717

Amounts reclassified from AOCI
 
(47
)
 
(429
)
 

 
41

 
(435
)
Deferred income tax benefit (expense)
 
22

 
149

 

 
(17
)
 
154

Amounts reclassified from AOCI, net of income tax
 
(25
)
 
(280
)
 

 
24

 
(281
)
Balance, end of period
 
$
13,469

 
$
1,569

 
$
(4,679
)
 
$
(1,923
)
 
$
8,436

 
 
Six Months
Ended
June 30, 2018
 
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
 
(In millions)
Balance, beginning of period
 
$
12,757

 
$
905

 
$
(4,390
)
 
$
(1,845
)
 
$
7,427

OCI before reclassifications
 
(6,907
)
 
(211
)
 
(417
)
 
(1
)
 
(7,536
)
Deferred income tax benefit (expense)
 
1,541

 
99

 
9

 

 
1,649

AOCI before reclassifications, net of income tax
 
7,391

 
793

 
(4,798
)
 
(1,846
)
 
1,540

Amounts reclassified from AOCI
 
128

 
305

 

 
62

 
495

Deferred income tax benefit (expense)
 
(29
)
 
(143
)
 

 
(13
)
 
(185
)
Amounts reclassified from AOCI, net of income tax
 
99

 
162

 

 
49

 
310

Cumulative effects of changes in accounting principles
 
(425
)
 

 

 

 
(425
)
Deferred income tax benefit (expense), cumulative effects of changes in accounting principles
 
1,473

 
210

 
36

 
(382
)
 
1,337

Cumulative effects of changes in accounting principles, net of income tax (2)
 
1,048

 
210

 
36

 
(382
)
 
912

Sale of subsidiary (3)
 

 

 
92

 

 
92

Balance, end of period
 
$
8,538

 
$
1,165

 
$
(4,670
)
 
$
(2,179
)
 
$
2,854

 
 
 
 
 
 
 
 
 
 
 
 
 
Six Months
Ended
June 30, 2017
 
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized
Gains (Losses)
on Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
 
(In millions)
Balance, beginning of period
 
$
10,785

 
$
1,865

 
$
(5,312
)
 
$
(1,972
)
 
$
5,366

OCI before reclassifications
 
3,993

 
203

 
517

 
(19
)
 
4,694

Deferred income tax benefit (expense)
 
(1,405
)
 
(70
)
 
116

 
5

 
(1,354
)
AOCI before reclassifications, net of income tax
 
13,373

 
1,998

 
(4,679
)
 
(1,986
)
 
8,706

Amounts reclassified from AOCI
 
149

 
(658
)
 

 
85

 
(424
)
Deferred income tax benefit (expense)
 
(53
)
 
229

 

 
(22
)
 
154

Amounts reclassified from AOCI, net of income tax
 
96

 
(429
)
 

 
63

 
(270
)
Balance, end of period
 
$
13,469

 
$
1,569

 
$
(4,679
)
 
$
(1,923
)
 
$
8,436

__________________
(1)
See Note 6 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI, and the policyholder dividend obligation.
(2)
See Note 1 for further information on adoption of new accounting pronouncements.
(3)
See Note 3 for further information on the 2018 disposition.
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Information regarding amounts reclassified out of each component of AOCI was as follows:
AOCI Components
 
Amounts Reclassified from AOCI
 
Consolidated Statements of
Operations and
Comprehensive Income (Loss)
Locations
 
 
Three Months
Ended
June 30,
 
Six Months
Ended
June 30,
 
 
 
 
2018
 
2017
 
2018

2017
 
 
 
 
(In millions)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
(36
)
 
$
44

 
$
(137
)
 
$
84

 
Net investment gains (losses)
Net unrealized investment gains (losses)
 
(3
)
 
(5
)
 

 
1

 
Net investment income
Net unrealized investment gains (losses)
 
(44
)
 
6

 
9

 
(145
)
 
Net derivative gains (losses)
Net unrealized investment gains (losses)
 

 
2

 

 
(89
)
 
Discontinued operations
Net unrealized investment gains (losses), before income tax
 
(83
)
 
47

 
(128
)
 
(149
)
 
 
Income tax (expense) benefit
 
19

 
(22
)
 
29

 
53

 
 
Net unrealized investment gains (losses), net of income tax
 
(64
)
 
25

 
(99
)
 
(96
)
 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
 
1

 
6

 
17

 
14

 
Net derivative gains (losses)
Interest rate swaps
 
6

 
3

 
9

 
7

 
Net investment income
Interest rate swaps
 

 
1

 

 
2

 
Discontinued operations
Interest rate forwards
 
(2
)
 

 
3

 
(4
)
 
Net derivative gains (losses)
Interest rate forwards
 

 
2

 
1

 
2

 
Net investment income
Interest rate forwards
 
1

 
1

 
1

 
1

 
Other expenses
Interest rate forwards
 

 
2

 

 
3

 
Discontinued operations
Foreign currency swaps
 
(475
)
 
413

 
(336
)
 
621

 
Net derivative gains (losses)
Foreign currency swaps
 
(1
)
 
(1
)
 
(1
)
 
(1
)
 
Net investment income
Foreign currency swaps
 

 

 
1

 
1

 
Other expenses
Foreign currency swaps
 

 
1

 

 
11

 
Discontinued operations
Credit forwards
 

 
1

 

 
1

 
Net derivative gains (losses)
Gains (losses) on cash flow hedges, before income tax
 
(470
)
 
429

 
(305
)
 
658

 
 
Income tax (expense) benefit
 
170

 
(149
)
 
143

 
(229
)
 
 
Gains (losses) on cash flow hedges, net of income tax
 
(300
)
 
280

 
(162
)
 
429

 
 
Defined benefit plans adjustment: (1)
 
 
 
 
 
 
 
 
 
 
Amortization of net actuarial gains (losses)
 
(35
)
 
(48
)
 
(71
)
 
(97
)
 
 
Amortization of prior service (costs) credit
 
4

 
7

 
9

 
12

 
 
Amortization of defined benefit plan items, before income tax
 
(31
)
 
(41
)
 
(62
)
 
(85
)
 
 
Income tax (expense) benefit
 
6

 
17

 
13

 
22

 
 
Amortization of defined benefit plan items, net of income tax
 
(25
)
 
(24
)
 
(49
)
 
(63
)
 
 
Total reclassifications, net of income tax
 
$
(389
)
 
$
281

 
$
(310
)
 
$
270

 
 
__________________
(1)
These AOCI components are included in the computation of net periodic benefit costs. See Note 12.